Literature DB >> 22767602

Dual-specificity tyrosine phosphorylation-regulated kinase 1A (Dyrk1A) modulates serine/arginine-rich protein 55 (SRp55)-promoted Tau exon 10 inclusion.

Xiaomin Yin1, Nana Jin, Jianlan Gu, Jianhua Shi, Jianhua Zhou, Cheng-Xin Gong, Khalid Iqbal, Inge Grundke-Iqbal, Fei Liu.   

Abstract

Tau exon 10, which encodes the second microtubule-binding repeat, is regulated by alternative splicing. Its alternative splicing generates Tau isoforms with three- or four-microtubule-binding repeats, named 3R-tau and 4R-tau. Adult human brain expresses equal levels of 3R-tau and 4R-tau. Imbalance of 3R-tau and 4R-tau causes Tau aggregation and neurofibrillary degeneration. In the present study, we found that splicing factor SRp55 (serine/arginine-rich protein 55) promoted Tau exon 10 inclusion. Knockdown of SRp55 significantly promoted Tau exon 10 exclusion. The promotion of Tau exon 10 inclusion by SRp55 required the arginine/serine-rich region, which was responsible for the subnucleic speckle localization. Dyrk1A (dual specificity tyrosine-phosphorylated and regulated kinase 1A) interacted with SRp55 and mainly phosphorylated its proline-rich domain. Phosphorylation of SRp55 by Dyrk1A suppressed its ability to promote Tau exon 10 inclusion. Up-regulation of Dyrk1A as in Down syndrome could lead to neurofibrillary degeneration by shifting the alternative splicing of Tau exon 10 to an increase in the ratio of 3R-tau/4R-tau.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22767602      PMCID: PMC3436298          DOI: 10.1074/jbc.M112.355412

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  45 in total

Review 1.  Sorting out the complexity of SR protein functions.

Authors:  B R Graveley
Journal:  RNA       Date:  2000-09       Impact factor: 4.942

Review 2.  Mutations causing neurodegenerative tauopathies.

Authors:  Michel Goedert; Ross Jakes
Journal:  Biochim Biophys Acta       Date:  2005-01-03

3.  A genome-wide Drosophila RNAi screen identifies DYRK-family kinases as regulators of NFAT.

Authors:  Yousang Gwack; Sonia Sharma; Julie Nardone; Bogdan Tanasa; Alina Iuga; Sonal Srikanth; Heidi Okamura; Diana Bolton; Stefan Feske; Patrick G Hogan; Anjana Rao
Journal:  Nature       Date:  2006-03-01       Impact factor: 49.962

4.  Functional interactions between the proline-rich and repeat regions of tau enhance microtubule binding and assembly.

Authors:  B L Goode; P E Denis; D Panda; M J Radeke; H P Miller; L Wilson; S C Feinstein
Journal:  Mol Biol Cell       Date:  1997-02       Impact factor: 4.138

5.  Dyrk1A phosphorylates alpha-synuclein and enhances intracellular inclusion formation.

Authors:  Eun Joo Kim; Jee Young Sung; Hyun Jung Lee; Hyewhon Rhim; Masato Hasegawa; Takeshi Iwatsubo; Do Sik Min; Jongsun Kim; Seung R Paik; Kwang Chul Chung
Journal:  J Biol Chem       Date:  2006-09-07       Impact factor: 5.157

6.  Domains of tau protein, differential phosphorylation, and dynamic instability of microtubules.

Authors:  B Trinczek; J Biernat; K Baumann; E M Mandelkow; E Mandelkow
Journal:  Mol Biol Cell       Date:  1995-12       Impact factor: 4.138

7.  Specific phosphorylation of SR proteins by mammalian DNA topoisomerase I.

Authors:  F Rossi; E Labourier; T Forné; G Divita; J Derancourt; J F Riou; E Antoine; G Cathala; C Brunel; J Tazi
Journal:  Nature       Date:  1996-05-02       Impact factor: 49.962

8.  Modulation of microtubule dynamics by tau in living cells: implications for development and neurodegeneration.

Authors:  Janis M Bunker; Leslie Wilson; Mary Ann Jordan; Stuart C Feinstein
Journal:  Mol Biol Cell       Date:  2004-03-12       Impact factor: 4.138

9.  Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer's disease.

Authors:  M Goedert; M G Spillantini; R Jakes; D Rutherford; R A Crowther
Journal:  Neuron       Date:  1989-10       Impact factor: 17.173

10.  The protein kinase DYRK1A phosphorylates the splicing factor SF3b1/SAP155 at Thr434, a novel in vivo phosphorylation site.

Authors:  Katrin de Graaf; Hanna Czajkowska; Sabine Rottmann; Len C Packman; Richard Lilischkis; Bernhard Lüscher; Walter Becker
Journal:  BMC Biochem       Date:  2006-03-02       Impact factor: 4.059

View more
  37 in total

Review 1.  The pathogenicity of splicing defects: mechanistic insights into pre-mRNA processing inform novel therapeutic approaches.

Authors:  Elisabeth Daguenet; Gwendal Dujardin; Juan Valcárcel
Journal:  EMBO Rep       Date:  2015-11-13       Impact factor: 8.807

Review 2.  Alzheimer disease therapeutics: focus on the disease and not just plaques and tangles.

Authors:  Khalid Iqbal; Fei Liu; Cheng-Xin Gong
Journal:  Biochem Pharmacol       Date:  2014-01-10       Impact factor: 5.858

3.  Comparative analysis of the DYRK1A-SRSF6-TNNT2 pathway in myocardial tissue from individuals with and without Down syndrome.

Authors:  Adolfo Quiñones-Lombraña; Javier G Blanco
Journal:  Exp Mol Pathol       Date:  2019-06-12       Impact factor: 3.362

4.  Transactive response DNA-binding protein 43 (TDP-43) regulates alternative splicing of tau exon 10: Implications for the pathogenesis of tauopathies.

Authors:  Jianlan Gu; Feng Chen; Khalid Iqbal; Cheng-Xin Gong; Xinglong Wang; Fei Liu
Journal:  J Biol Chem       Date:  2017-05-09       Impact factor: 5.157

5.  DYRK1A regulates B cell acute lymphoblastic leukemia through phosphorylation of FOXO1 and STAT3.

Authors:  Rahul S Bhansali; Malini Rammohan; Paul Lee; Anouchka P Laurent; Qiang Wen; Praveen Suraneni; Bon Ham Yip; Yi-Chien Tsai; Silvia Jenni; Beat Bornhauser; Aurélie Siret; Corinne Fruit; Alexandra Pacheco-Benichou; Ethan Harris; Thierry Besson; Benjamin J Thompson; Young Ah Goo; Nobuko Hijiya; Maria Vilenchik; Shai Izraeli; Jean-Pierre Bourquin; Sébastien Malinge; John D Crispino
Journal:  J Clin Invest       Date:  2021-01-04       Impact factor: 14.808

Review 6.  Faulty RNA splicing: consequences and therapeutic opportunities in brain and muscle disorders.

Authors:  Vittoria Pagliarini; Piergiorgio La Rosa; Claudio Sette
Journal:  Hum Genet       Date:  2017-04-22       Impact factor: 4.132

7.  Huntington's disease is a four-repeat tauopathy with tau nuclear rods.

Authors:  Marta Fernández-Nogales; Jorge R Cabrera; María Santos-Galindo; Jeroen J M Hoozemans; Isidro Ferrer; Annemieke J M Rozemuller; Félix Hernández; Jesús Avila; José J Lucas
Journal:  Nat Med       Date:  2014-07-20       Impact factor: 53.440

Review 8.  The genomically mosaic brain: aneuploidy and more in neural diversity and disease.

Authors:  Diane M Bushman; Jerold Chun
Journal:  Semin Cell Dev Biol       Date:  2013-03-04       Impact factor: 7.727

9.  Isoform-independent and -dependent phosphorylation of microtubule-associated protein tau in mouse brain during postnatal development.

Authors:  Dilina Tuerde; Taeko Kimura; Tomohiro Miyasaka; Kotaro Furusawa; Aki Shimozawa; Masato Hasegawa; Kanae Ando; Shin-Ichi Hisanaga
Journal:  J Biol Chem       Date:  2017-12-01       Impact factor: 5.157

Review 10.  Regulation of alternative splicing of tau exon 10.

Authors:  Wei Qian; Fei Liu
Journal:  Neurosci Bull       Date:  2014-03-14       Impact factor: 5.203

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.